Prion diseases and the immune system

Clinical Immunology

Volumn 96, Issue 2, 2000, Pages 79-85

  Aucouturier, Pierre ^a,b   Carp, Richard I ^c   Carnaud, Claude ^b   Wisniewski, Thomas ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Immune tolerance; Lymphoid organs; PrP

Indexed keywords

HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; LYMPHOID TISSUE; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033857598     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4875     Document Type: Review

References (72)

1. The prion diseases of humans and animals
2. The prionoses and other conformational disorders
3. Prion protein amyloid and neurodegeneration
4. Transmissible spongiform encephalopathies
5. Deadly conformations - Protein misfolding in prion disease [Review]
6. The environmental dependency of protein folding best explains prion and amyloid diseases
7. Biology of Prions
8. Prion protein biology
9. Encephalopathy in mice produced by inoculation with scrapie brain material
10. Encephalopathy of mink. II. Experimental and natural transmission
11. Variation in the characteristics of 10 mouse-passaged scrapie lines derived from five scrapie-positive sheep
12. Diversity and significance of scrapie strains
13. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
14. Failure to demonstrate a humoral immune response to scrapie infection in mice
15. Evidence for normal cell-mediated immunity in scrapie-infected mice
16. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
17. Insights into the role of the immune system in prion diseases
18. In vitro interaction of scrapie agent and mouse peritoneal macrophages
19. Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation
20. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies
21. Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein
22. Mice devoid of PrP are resistant to scrapie
23. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice
24. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
25. Suppression of polyclonal B cell activation in scrapie-infected C3H/HeJ mice
26. Further studies on changes in immunoglobulin G in the sera and CSF of Herdwick sheep with natural and experimental scrapie
27. Polyclonal increase in certain IgG subclasses in mice persistently infected with the 87V strain of scrapie
28. Immunological responsiveness of scrapie infected mice
29. Pathogenesis of scrapie virus infection in the mouse
30. Pathogenesis of scrapie in the mouse: The role of the spleen
31. Studies of the lymphoreticular system in the pathogenesis of scrapie: The role of spleen and thymus
32. Pathogenesis of mouse scrapie: Dynamics of agent replication in spleen, spinal cord and brain after injection by different routes
33. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
34. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
35. Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve
36. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly
37. Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system
38. Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy
39. A crucial role for B cells in neuroinvasive scrapie
40. Scrapie pathogenesis in subclinically infected B-cell-deficient mice
41. Developmental maturation of susceptibility to scrapie in mice
42. Reduced susceptibility to scrapie in mice after steroid administration
43. Mitogenic stimulation of the host enhances susceptibility to scrapie
44. Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow
45. Immune system-dependent and -independent replication of the scrapie agent
46. Creutzfeldt-Jakob disease in mice: Persistent viremia and preferential replication of virus in low-density lymphocytes
47. Ionising radiation has no influence on scrapie incubation period in mice
48. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease
49. Dendritic cells and the control of immunity
50. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells
51. PrP expression in B lymphocytes is not required for prion neuroinvasion
52. Induction of functional follicular dendritic cell development in severe combined immunodeficiency mice. Influence of B and T cells
53. Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication
54. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice
55. Prion protein expression in human leukocyte differenciation
56. Characterization of PrP binding proteins
57. Identification of candidate proteins binding to prion protein
58. Complementary hydropathy identifies a cellular prion protein receptor
59. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells
60. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP
61. Chaperone-supervised conversion of prion protein to its protease-resistant form
62. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation
63. Molecular neuropathology of prion diseases
64. Sustained viremia in experimental hamster scrapie. Brief report
65. Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie
66. Viremia in experimental Creutzfeldt-Jakob disease
67. Neurodegenerative disease - B cells may propagate prions
68. Further characterization of scrapie replication in PC12 cells
69. Characterization of scrapie infection in mouse neuroblastoma cells
70. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains
71. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
72. Post-exposure prophylaxis after accidental prion inoculation